TITLE:
A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

CONDITION:
Carcinoma, Renal Cell

INTERVENTION:
SU011248

SUMMARY:

      To assess the safety and efficacy of SU011248 in patients with metastatic, refractory renal
      cell carcinoma
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Cytokine refractory metastatic renal cell carcinoma with clear cell component

          -  Radiographic evidence of disease progression during or within 9 months of completion
             of 1 cytokine therapy

          -  Prior nephrectomy

        Exclusion Criteria:

          -  Prior treatment with any systemic therapy other than 1 cytokine therapy

          -  History of or known brain metastases

          -  Uncontrolled hypertension or other significant cardiac events within the 12 months
             prior to study start
      
